September 10, 2007 - Four analyses of three-year follow-up data that were presented at the ESC Congress 2007 showed that ...
September 7, 2007 - Gary Ansel, M.D., Riverside Methodist Hospital, successfully implanted the GORE VIABAHN ...
iffering approaches for the treatment of coronary bifurcation and ostial lesions (CBOL) continue to feed the debate over which stent designs and stenting techniques are most effective.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
September 6, 2007 — ProSolv CardioVascular, a FUJIFILM company (ProSolv), announced at the 12th Annual Scientific ...
Just when drug-eluting stents (DES) were going to revolutionize interventional cardiology, new reports that DES may be associated with increased risk of late-stent thrombosis have many physicians putting the brakes on DES use. Despite this significant bump in the road, stent manufacturers are forging ahead with clinical trials on novel systems and on plans to roll out new DES platforms in 2008.
September 10, 2007 - Signalife launched the sales of its new, FDA-approved, ambulatory 12-lead ECG cardiovascular ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Combining all features of the ACIST CMS and Voyager systems onto one platform, the ACIST CVi Contrast Delivery System ...
Sony Electronics recently introduced its LMD-2450MD 24-inch monitor, which offers 10-bit signal processing and Sony ...
Possis Medical Inc. will feature the newest advancements in its “Complete Solution for Thrombus,” including the AngioJet Ultra Thrombectomy System, AngioJet Spiroflex and Spiroflex VG catheters and its Fetch Aspiration Catheter.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Cordis Endovascular announced, at the 61st Annual Meeting of the Society for Vascular Surgery, the worldwide launch of ...
September 6, 2007 - While few complications were found last year with implantable cardioverter defibrillators (ICDs), 15 ...
Guerbet’s flagship X-ray contrast agent, Oxilan (ioxilan) injection, is a contrast agent that is a nonionic, low-viscous ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 5, 2007 – According to Boston Scientific Corp., results from the TAXUS WOMAN study, a gender specific analysis ...
Siemens Medical Solutions Ultrasound Division’s syngo Arterial Health Package (AHP) application for cardiovascular risk ...
GE Healthcare Medical Diagnostics’ VISIPAQUE is reportedly the only isosmolar contrast medium (IOCM) available in the U.S. With an osmolality equal to that of blood, VISIPAQUE was designed for patient safety and comfort and is also formulated with sodium and calcium in a ratio equivalent to blood.
September 09, 2007
